{
    "nct_id": "NCT03983577",
    "official_title": "Efficacy of Point Of Service Testing in Metastatic Breast Cancer",
    "inclusion_criteria": "* Ability of participant OR Legally Authorized Representative (LAR) to understand this study, and participant or LAR willingness to sign a written informed consent.\n* Able to speak and read in the English language.\n* Have a diagnosis of human epidermal growth factor receptor 2 (HER2) negative metastatic breast cancer.\n* Participants must be enrolled in the parent registry study.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Genetic testing for a breast cancer gene (BRCA) BRCA1 and BRCA2 mutation completed after 2013 or any BRCA 1 and BRCA2 testing with large rearrangement testing. Prior genetic counseling is allowed.\n* Psychiatric illness/social situations that would limit compliance with study requirements.",
    "miscellaneous_criteria": ""
}